New Industry Standards for Bioequivalence Testing on 43 Ingredients

Published: 2005-03-03 06:57:00

Updated: 2005-03-03 06:57:00

The Korea Food and Drug Administration (KFDA) recently released the standard bioequivalence testing guidance on 43 pharmaceutical active ingredients, including gabapentin, glimepiride, rebamipide, and cefroxidine, among others.

With these additions, there are currently 139 active ingredients ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK